Related Experiment Video
Updated: May 26, 2026
06:45
A Mouse Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Procedure Aided by Microscopy
Published on: January 19, 2024
[Personalised hepatology - current concepts, developments and expectations in the post-genome era]
A Teufel1, J U Marquardt, S Dooley
1Medizinische Klinik und Poliklinik, Universitätsmedizin, Mainz, Germany.
Zeitschrift Fur Gastroenterologie
|January 7, 2012
Summary
Personalised medicine offers tailored, effective, and economical treatments for chronic liver disease by utilizing genetic insights. Future advancements require enhanced knowledge, standardized technologies, and robust bioinformatics for clinical integration.
Area of Science:
- Genomics and Translational Medicine
- Hepatology and Personalized Therapeutics
Context:
- The decoding of the human genome has propelled personalized medicine into a realistic therapeutic strategy.
- Chronic liver diseases can benefit from individualized treatment approaches for improved efficacy and reduced side effects.
Purpose:
- To review the current progress and potential of personalized medicine in hepatological diseases.
- To identify and characterize biomarkers for individualized diagnosis, prognosis, and treatment.
- To explain technical limitations hindering clinical implementation.
Summary:
- Personalized medicine in hepatology leverages genetic "fingerprints" for tailored patient care.
- Examples include optimizing hepatitis C treatment through viral genotyping and IL28B polymorphism analysis.
- Key challenges involve expanding knowledge, standardizing technologies, and developing advanced bioinformatics strategies.
Impact:
- Enables more effective, safer, and cost-efficient therapies for chronic liver conditions.
- Facilitates the development of genetic biomarkers for precise diagnosis and prognosis.
- Highlights the need for technological and data integration advancements for widespread clinical adoption.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...